insights_auto
Why is BOT down 6.67%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.014
arrow_downward
-6.67%(-0.00100) 1D
Oct 9, 4:10:30 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.02
High
A$0.02
Low
A$0.01
Mkt. cap
29.00M
Avg. vol.
6.53M
Volume
5.03M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.02
High
A$0.02
Low
A$0.01
Mkt. cap
29.00M
Avg. vol.
6.53M
Volume
5.03M
52-wk high
A$0.17
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
The Manila Times
·
30 minutes ago
IT Tech Packaging, Inc. Announces NYSE Regulation Acceptance of Extension Request; Listing Continued Pursuant to Extension Through April 15, 2027
The Motley Fool
·
2 minutes ago
I've Owned the Vanguard S&P 500 ETF for 6 Years. Here's Why I'm Not Selling.
Yahoo Finance
·
29 minutes ago
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Seeking Alpha
·
43 minutes ago
S&P 500’s top five stocks match market cap of bottom 434, Batnick says
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd